ECSP045134A - Monohidrato de clorhidrato de venlafaxina y métodos para la preparación del mismo - Google Patents

Monohidrato de clorhidrato de venlafaxina y métodos para la preparación del mismo

Info

Publication number
ECSP045134A
ECSP045134A EC2004005134A ECSP045134A ECSP045134A EC SP045134 A ECSP045134 A EC SP045134A EC 2004005134 A EC2004005134 A EC 2004005134A EC SP045134 A ECSP045134 A EC SP045134A EC SP045134 A ECSP045134 A EC SP045134A
Authority
EC
Ecuador
Prior art keywords
methods
venlafaxine
monohidrate
chlorhydrate
preparation
Prior art date
Application number
EC2004005134A
Other languages
English (en)
Inventor
Jun Han
Yong Jai Lee
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP045134A publication Critical patent/ECSP045134A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención relaciona una forma polimórfico cristalino de clorhidrato de venlafaxina el cual existe en forma hidratada (por ejemplo, como un monohidrato), métodos para la preparación del mismo, y su uso.
EC2004005134A 2001-12-05 2004-06-04 Monohidrato de clorhidrato de venlafaxina y métodos para la preparación del mismo ECSP045134A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33582301P 2001-12-05 2001-12-05

Publications (1)

Publication Number Publication Date
ECSP045134A true ECSP045134A (es) 2004-07-23

Family

ID=23313363

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005134A ECSP045134A (es) 2001-12-05 2004-06-04 Monohidrato de clorhidrato de venlafaxina y métodos para la preparación del mismo

Country Status (20)

Country Link
US (2) US20030114536A1 (es)
EP (1) EP1451146A1 (es)
JP (1) JP2005511737A (es)
KR (1) KR20050044711A (es)
CN (1) CN1599715A (es)
AR (1) AR037636A1 (es)
AU (1) AU2002366574A1 (es)
BR (1) BR0214696A (es)
CA (1) CA2467614A1 (es)
CO (1) CO5580817A2 (es)
EC (1) ECSP045134A (es)
HU (1) HUP0402553A2 (es)
MX (1) MXPA04005307A (es)
NO (1) NO20042810L (es)
PL (1) PL370559A1 (es)
RU (1) RU2004120273A (es)
TW (1) TW200300669A (es)
UA (1) UA77234C2 (es)
WO (1) WO2003050076A1 (es)
ZA (1) ZA200405245B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1630631A (zh) * 2001-12-05 2005-06-22 惠氏公司 新的文拉法星盐酸盐多晶型物及其制备方法
CA2574315A1 (en) * 2004-07-22 2006-02-02 Wyeth Method for treating nervous system disorders and conditions
US20060020015A1 (en) * 2004-07-22 2006-01-26 Wyeth Method for treating nervous system disorders and conditions
AU2005266997A1 (en) * 2004-07-22 2006-02-02 Wyeth Method for treating nervous system disorders and conditions
KR20080056311A (ko) * 2005-10-19 2008-06-20 테바 파마슈티컬 인더스트리즈 리미티드 고순도1-[2-디메틸아미노-(4-메톡시페닐)에틸)시클로헥산올염산염의 제조 방법
CN101484411A (zh) 2006-06-27 2009-07-15 桑多斯股份公司 盐的新制备方法
EP2357183B1 (en) 2007-05-01 2015-07-01 Concert Pharmaceuticals Inc. Morphinan compounds
US20120083487A1 (en) * 2008-10-30 2012-04-05 Amanda Thomas Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurolgical diseases, intractable and chronic pain and brain injury
CA2995395C (en) 2015-08-31 2024-04-16 Nutramax Laboratories, Inc. Compositions comprising magnolia, phellodendron, theanine and/or whey protein

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69429895T2 (de) * 1993-06-28 2002-08-29 American Home Products Corp., Madison Neue Behandlungsmethoden durch Verwendung von Phenethylderivaten
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
US5506270A (en) * 1995-01-30 1996-04-09 American Home Products Corporation Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
KR20030059206A (ko) * 2000-10-19 2003-07-07 테바 파마슈티컬 인더스트리즈 리미티드 결정질 벤라팍신 염기 및 벤라팍신 히드로클로라이드의신규한 다형태, 이의 제조 방법
AU2002212340B2 (en) * 2000-10-31 2006-12-14 Sandoz Ag Crystalline forms of venlafaxine hydrochloride
WO2002046140A1 (en) * 2000-12-07 2002-06-13 Dr. Reddy's Laboratories Ltd. Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Also Published As

Publication number Publication date
RU2004120273A (ru) 2005-03-27
ZA200405245B (en) 2007-01-31
AU2002366574A1 (en) 2003-06-23
TW200300669A (en) 2003-06-16
UA77234C2 (en) 2006-11-15
NO20042810L (no) 2004-07-02
PL370559A1 (en) 2005-05-30
EP1451146A1 (en) 2004-09-01
US20030114536A1 (en) 2003-06-19
BR0214696A (pt) 2004-11-03
CN1599715A (zh) 2005-03-23
AR037636A1 (es) 2004-11-17
CA2467614A1 (en) 2003-06-19
MXPA04005307A (es) 2004-09-13
US20050272822A1 (en) 2005-12-08
WO2003050076A1 (en) 2003-06-19
KR20050044711A (ko) 2005-05-12
JP2005511737A (ja) 2005-04-28
HUP0402553A2 (hu) 2005-03-29
CO5580817A2 (es) 2005-11-30

Similar Documents

Publication Publication Date Title
TW200716512A (en) Processes for preparing cinacalcet hydrochloride crystal form I
IL186701A0 (en) C. perfringens alpha toxoid vaccine
PA8561301A1 (es) Moleculas pequenas para el tratamiento del crecimiento celular anormal
ITMI20020973A0 (it) Macchina per la preparazione di bevande
ITMI20052085A1 (it) Tutore ambidestro per polso provvisto di immobilizzatore del pollice
UY31758A (es) Forma cristalina anhidra de maleato de orvepitant
ECSP045134A (es) Monohidrato de clorhidrato de venlafaxina y métodos para la preparación del mismo
ITMI20052204A1 (it) Uso di colostro per la profilassi delle sindroni influenzali
AR058173A1 (es) Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas
ITMI20031144A0 (it) Analoghi del colchicoside
ITMI20031994A1 (it) Procedimento per la preparazione di fludarabina fosfato
ITTO20040450A1 (it) Procedimento per la produzione di una sede di valvola.
ITMI20041920A1 (it) Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina
ITTO20030850A1 (it) Procedimento per la preparazione di 4-ammino-3,5-dicloro-benzotrifloruro.
ITMI20041941A1 (it) Processo per la preparazione di lisofosfatidilcoline
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
ITMI20040452A1 (it) Processo per la preparazione di oxcarbazepina
ITMI20051971A1 (it) Procedimento per la preparazione di - modafinil
ITMI20041086A1 (it) Procedimento per la preparazione di idrocarbilalogenuri
TW200640836A (en) Processes for preparing sertraline
ITMI20050278A1 (it) Procedimento per la preparazione del toremifene
IL187659A0 (en) Process for the preparation of n,n'-disubstituted oxabispidines
ITMI20050892A1 (it) Procedimento per la preparazione di ossazolidin-2,4-dioni
ITMI20032069A1 (it) Procedimento per la preparazione di derivati benzilmidazolici.
ITVR20050027U1 (it) Dispositivo di aggancio, particolarmente per la connessione reciproca di sedie accostate.